1. Assessing Disparities in the Rates of HCV Diagnoses Within American Indian or Alaska Native Populations Served by the U.S. Indian Health Service, 2005–2015
- Author
-
Melissa G. Collier, Brigg Reilley, Mona Doshani, Jorge Mera, Jessica Leston, Jonathan Iralu, Thomas Weiser, Dana L. Haberling, Marissa Person, and Rick Haverkate
- Subjects
Adult ,Male ,medicine.medical_specialty ,Health (social science) ,Hepacivirus ,03 medical and health sciences ,Health services ,Sex Factors ,0302 clinical medicine ,medicine ,Humans ,030212 general & internal medicine ,Medical diagnosis ,American Indian or Alaska Native ,Computers ,business.industry ,Public Health, Environmental and Occupational Health ,Hepatitis C Antibodies ,Alaskan Natives ,Hepatitis C ,United States ,Medical services ,Inuit ,Family medicine ,United States Indian Health Service ,Indians, North American ,Female ,030211 gastroenterology & hepatology ,business - Abstract
Hepatitis C virus (HCV) disproportionately affects American Indians/Alaska Natives (AI/AN). The Indian Health Service (IHS), via federal and tribal health facilities provides medical services to an estimated 2.2 million AI/AN people in the United States. HCV diagnoses, defined by International Classification of Diseases 9th Revision, Clinical Modification (ICD-9-CM) codes, were analyzed from 2005 to 2015. Results showed 29,803 patients with an HCV diagnosis; 53.4% were among persons born 1945-1965 and overall HCV burden was higher among males than females. These data will help inform local, regional, and national efforts to address, plan for and carry out a national strategy to provide treatment for HCV infected patients and programs to prevent new HCV infections.
- Published
- 2018